Journal profile · PSYCHIATRY
Harvard Review of Psychiatry
ISSN 1067-3229 · eISSN 1465-7309 · Lippincott Williams and Wilkins Ltd. · UNITED STATES
Harvard Review of Psychiatry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.89; JCR Q2 (journal website); hybrid open access; median 136 days to acceptance (26 articles, last 24 months); 35 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
Harvard Review of Psychiatry is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Mental Health and Psychiatry and Psychotherapy Techniques and Applications, together about 26.8% of its articles. Its main subfields are Clinical Psychology and Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on important topics in psychiatry. Founded by the Harvard Medical School's Department of Psychiatry, the Harvard Review of Psychiatry features review papers that summarize and synthesize the key literature in a scholarly and clinically relevant manner. Topics covered include: Schizophrenia and related disorders; Mood disorders; Personality disorders; Substance use disorders; Anxiety; Neuroscience; Psychosocial aspects of psychiatry; Ethics; Psychiatric education; and much more. In addition, a Clinical Challenges section presents a case with discussion from a panel of experts. Brief reviews are presented in topic-specific columns that include Cross-Cultural Psychiatry, History of Psychiatry, Ethics, and others.
Source: LetPub
Research area (LetPub): PSYCHIATRY
Editor-in-chief Joshua L. RoffmanPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine10.8%
- Mental Health and PsychiatryArts and Humanities9.3%
- Psychotherapy Techniques and ApplicationsPsychology6.8%
- Bipolar Disorder and TreatmentMedicine6.5%
- Mental Health Treatment and AccessPsychology6%
- Child and Adolescent Psychosocial and Emotional DevelopmentPsychology5.8%
- Personality Disorders and PsychopathologyPsychology5.7%
- Treatment of Major DepressionMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · PSYCHIATRY · rank 119/293
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.89LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 1.36LetPub ·
- h-index
- 68LetPub ·
- h-index
- 121OpenAlex ·
- i10-index
- 794OpenAlex ·
- 2-year mean citedness
- 2.55OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 16.67%LetPub ·
Volume
- Articles per year
- 30LetPub ·
Articles by year OpenAlex count · 1,564 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 7 | 15 |
| 2025 | 35 | 8 | 88 |
| 2024 | 30 | 9 | 134 |
| 2023 | 35 | 14 | 423 |
| 2022 | 34 | 13 | 685 |
| 2021 | 44 | 12 | 686 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
136 daysMedian, submission to acceptance · P25–P75 110 days – 169 days
- Acceptance to online
- median 115 days (21 articles)
- Submission to online
- median 246 days
- Sample
- 26 articles with submission and acceptance dates (73 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1067-3229
- Print ISSN
- 1465-7309
- Electronic ISSN
- 1465-7309
- Latest issue on the website
- Volume 34, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Harvard Review of Psychiatry
What CAS zone is Harvard Review of Psychiatry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Harvard Review of Psychiatry is in Zone 4 of Medicine, and in Zone 4 of the minor category Psychiatry. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Harvard Review of Psychiatry?
The latest impact factor listed by LetPub is 2.89; CiteScore 6.2, h-index 121.
How long does peer review take at Harvard Review of Psychiatry?
Based on the dates recorded on 26 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 136 days (interquartile range 110–169 days); authors report an average review time of over 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Harvard Review of Psychiatry in?
The journal's website gives JCR Q2; by category, PSYCHIATRY Q2 (119/293). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Harvard Review of Psychiatry?
According to LetPub and DOAJ records, Harvard Review of Psychiatry is indexed in SCIE, SSCI and Scopus.
Is Harvard Review of Psychiatry open access, and what is the APC?
Harvard Review of Psychiatry is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .